Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Tejaswini Dhawale, M.D.

Concepts (66)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematologic Neoplasms5202419050.660 Why?
Lymphoma, Extranodal NK-T-Cell12017480.550 Why?
Terminal Care2202417730.490 Why?
Uncertainty120177590.390 Why?
Lymphoma, Non-Hodgkin3202413760.340 Why?
Quality of Life82024135030.300 Why?
Telemedicine1202431070.280 Why?
Neoplasms32024223850.260 Why?
Hematopoietic Stem Cell Transplantation3202157130.260 Why?
Physician-Patient Relations1201732670.220 Why?
Immunotherapy, Adoptive3202415080.200 Why?
Lung Neoplasms12024135760.170 Why?
Adaptation, Psychological3202426630.150 Why?
Anxiety5202446770.150 Why?
Lymphocyte Depletion120196050.140 Why?
Leukemia, Myeloid, Acute2202236200.130 Why?
Empathy120214760.130 Why?
Perception1202212050.130 Why?
Antigens, CD19120194370.130 Why?
International Classification of Diseases120219240.120 Why?
Neurotoxicity Syndromes120193020.120 Why?
Prognosis52024300220.120 Why?
Patient Acceptance of Health Care2202432310.110 Why?
Depression4202482410.090 Why?
Social Support1202121910.090 Why?
Receptors, Antigen, T-Cell1201925680.080 Why?
Communication1202439120.080 Why?
Palliative Care1202436430.080 Why?
Graft vs Host Disease1202130440.080 Why?
Cross-Sectional Studies32024263750.070 Why?
T-Lymphocytes12024102670.070 Why?
Humans1620247683930.060 Why?
Immunotherapy1201947380.050 Why?
Electronics120213170.040 Why?
Aged, 80 and over12024596860.040 Why?
Physicians1201746140.040 Why?
Middle Aged520242234910.040 Why?
Retrospective Studies22024818010.040 Why?
Antineoplastic Combined Chemotherapy Protocols12019118540.040 Why?
Vidarabine120193370.040 Why?
Longitudinal Studies22024147840.030 Why?
Death120216830.030 Why?
Male520243649020.030 Why?
Aged220241715620.030 Why?
Checklist120218440.030 Why?
Cyclophosphamide1201922260.030 Why?
Female420243970890.030 Why?
Caregivers1202423030.020 Why?
Regression Analysis1202163500.020 Why?
Pilot Projects1202487310.020 Why?
Disease Management1201925370.020 Why?
Massachusetts1202189020.020 Why?
Socioeconomic Factors1202178610.020 Why?
Combined Modality Therapy1201985620.020 Why?
Clinical Trials as Topic1202280510.020 Why?
Databases, Factual1202180750.020 Why?
Adult320242236400.020 Why?
Neoplasm Recurrence, Local1202394330.010 Why?
Survival Rate12019128700.010 Why?
Delivery of Health Care1202153750.010 Why?
Stress Disorders, Post-Traumatic1202146410.010 Why?
Algorithms12021141540.010 Why?
Follow-Up Studies12019394070.010 Why?
Adolescent12024891840.010 Why?
Treatment Outcome12021653790.010 Why?
Animals120191693370.000 Why?
Dhawale's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (66)
Explore
_
Co-Authors (18)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.